Content - Research grants

Research Grants

  • SAKK / Amgen Research Grant

    SAKK and Amgen Switzerland AG award the SAKK / Amgen Research Grant every two years for outstanding and novel translational cancer research in Switzerland that improves patient’s lives. The grant is endowed with CHF 50'000.-.
    Researchers or a research team independent of their nationality and age, working at a Swiss hospital or institution can apply for the SAKK / Amgen research grant. The grant should contribute to an independent research project and cover a relevant scientific part of the project.

    SAKK / Amgen Research Grant 2017: The call for application for the SAKK / Amgen Research Grant 2017 is now open until August 31th, 2017. Submissions have to be sent electronically to

    Regulations / Flyer

  • SAKK / Astellas GU-Oncology Award

    To further preclinical and clinical oncology research in Switzerland, SAKK and Astellas team up to confer the Swiss GU-Oncology Award. A researcher will be awarded as representative of a research group or project for an outstanding scientific and/or clinical achievement documented by a scientific publication (published paper or accepted manuscript in a peer-reviewed journal).

    The focus of the SAKK / Astellas GU-Oncology Award lies on potential tangible improvements for patient management and outcomes in the treatment of genitourinary cancers.

    The award is endowed with CHF 30’000.- and should encourage the continuation of research activities. Hence the awarded sum is to be used for ongoing and future research within the respective research group or project.

    SAKK / Astellas GU-Oncology Award 2017: The call for application for the SAKK / Astellas GU-Oncology Award 2017 is now open until September 30th, 2017. Full applications can be sent via email to

    Regulations SAKK / Astellas GU-Oncology Award 2017

  • The RTFCCR / SAKK Research Grant

    Swiss Group for Clinical Cancer Research (SAKK) and the Rising Tide Foundation for Clinical Cancer Research (RTFCCR) have joined forces for this unique opportunity to attract high quality clinical studies focusing on confirming the need of treatment.  

    Additional treatments can sometimes be more harmful than beneficial and are costly. Unnecessary treatments with undesirable side effects should therefore be avoided as it impairs patients’ quality of life significantly.  

    We call upon all investigators to submit clinical research proposals for patient-centered clinical trials aimed at addressing this critical question: Do we overtreat our patients? The amount available for this call for proposals is CHF 1 million. Max. 3 projects will be funded. More Information can be found here.  

    Application Deadline: October 2, 2017

    Research proposals must be submitted through proposalCENTRAL. The winning proposals will be announced in the 2nd quarter of 2018

  • Life Grant

    Pancreatic cancer remains a devastating disease associated with a poor survival prognosis and a significant impairment of the quality of life of patients and their relatives. SAKK and Celgene share a common interest in innovative research for life-changing medication and therapeutic concepts for patients with high unmet medical needs. The Life Grant supports planned or ongoing research projects in pancreatic cancer care aiming to improve the quality of life of patients and their relatives.

    The call for proposals for the Life Grant 2017 is closed.

  • SAKK / Dr. Paul Janssen Fellowship

    SAKK and Janssen-Cilag AG have decided to jointly award a fellowship endowed with CHF 30'000.-. The educational grant is aimed at offering young doctors the opportunity to spend up to four months at a renowned research center abroad to gain experience and acquire the necessary know-how and tools to develop and conduct top-quality clinical trials.

    The call for proposals for the SAKK / Dr. Paul Janssen Fellowship 2017 is closed.

  • SAKK / Pfizer Award

    SAKK and Pfizer AG (Switzerland) jointly award the SAKK / Pfizer Award endowed with CHF 20'000.- every two years. The award honors patient-oriented, practice-relevant research in clinical oncology.
    Medical professionals below the age of 50 are welcome to apply for the SAKK / Pfizer Award by submitting their research work in the form of a scientific publication. The manuscript must be either published within the last year or be submitted for publication in a peer-reviewed journal. The publication must directly contribute to the improvement of cancer treatment and patient outcome.

    The call for proposals for the SAKK / Pfizer Award 2017 is closed.

Other information:

Dennis Ammann
SAKK Coordinating Center
Effingerstrasse 33
3008 Bern
Tel +41 31 508 41 75